Developing Web Application for Virtual Screening and Prediction of Breast Cancer Drugs: Target Interaction and Drug Approval Using Machine Learning-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Developing Web Application for Virtual Screening and Prediction of Breast Cancer Drugs: Target Interaction and Drug Approval Using Machine Learning

Published:2023-04-14 Issue: Volume: Page:
ISSN:
Container-title:2023 IEEE 3rd International Conference on Electronic Communications, Internet of Things and Big Data (ICEIB)
language:
Short-container-title:

Author:

Chumsang Jantharat¹,Phangsee Thanaphon¹,Wiriyaprapanont Nattaporn¹,Arromrit Trirat¹,Prom-On Santitham¹,Mahikul Wiriya²

Affiliation:

1. King Mongkut’s University of Technology Thonburi,Faculty of Engineering,Department of Computer Engineering,Bangkok,Thailand

2. Chulabhorn Royal Academy,Princess Srisavangavadhana College of Medicine,Bangkok,Thailand

Funder

Chulabhorn Royal Academy

Publisher

IEEE

Link

http://xplorestaging.ieee.org/ielx7/10169134/10169905/10170500.pdf?arnumber=10170500

Reference14 articles.

1. Deep Learning Approach for Discovery of In Silico Drugs for Combating COVID-19

2. Genomics & Targeted therapy of Breast Cancers, Bangkok, 2021;ravat,0

3. Severely imbalanced Big Data challenges: investigating data sampling approaches

4. SMILES Tutorial,0

5. Appendix F. SMILES Notation Tutorial,0

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP